Publications by authors named "Ettore Biagi"

Claim this Profile
L
Lenalidomide enhances CD23.CAR T cell therapy in chronic lymphocytic leukemia.
Sarah Tettamanti, Maria Caterina Rotiroti, Greta Maria Paola Giordano Attianese, Silvia Arcangeli, Ronghua Zhang, Ettore Biagi

Leuk Lymphoma· July 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleeping Beauty-engineered CAR T cells achieve antileukemic activity without severe toxicities.
Chiara F Magnani, Giuseppe Gaipa, Federico Lussana, Daniela Belotti, Giuseppe Gritti, Ettore Biagi

J Clin Invest· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting CD33 in Chemoresistant AML Patient-Derived Xenografts by CAR-CIK Cells Modified with an Improved SB Transposon System.
Maria Caterina Rotiroti, Chiara Buracchi, Silvia Arcangeli, Stefania Galimberti, Maria Grazia Valsecchi, Ettore Biagi

Mol Ther· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Engineered T cells towards TNFRSF13C (BAFFR): a novel strategy to efficiently target B-cell acute lymphoblastic leukaemia.
Nice Turazzi, Grazia Fazio, Valentina Rossi, Antonius Rolink, Giovanni Cazzaniga, Ettore Biagi

Br J Haematol· September 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
TNFRSF13C (BAFFR) positive blasts persist after early treatment and at relapse in childhood B-cell precursor acute lymphoblastic leukaemia.
Grazia Fazio, Nice Turazzi, Valeria Cazzaniga, Matthias Kreuzaler, Oscar Maglia, Ettore Biagi

Br J Haematol· August 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Preclinical Efficacy and Safety of CD19CAR Cytokine-Induced Killer Cells Transfected with Sleeping Beauty Transposon for the Treatment of Acute Lymphoblastic Leukemia.
Chiara F Magnani, Claudia Mezzanotte, Claudia Cappuzzello, Michela Bardini, Sarah Tettamanti, Ettore Biagi

Hum Gene Ther· May 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Phase II Study of Sequential Infusion of Donor Lymphocyte Infusion and Cytokine-Induced Killer Cells for Patients Relapsed after Allogeneic Hematopoietic Stem Cell Transplantation.
Martino Introna, Federico Lussana, Alessandra Algarotti, Elisa Gotti, Rut Valgardsdottir, Ettore Biagi

Biol Blood Marrow Transplant· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Redirecting T cells with Chimeric Antigen Receptor (CAR) for the treatment of childhood acute lymphoblastic leukemia.
Andrea Biondi, Chiara F Magnani, Sarah Tettamanti, Giuseppe Gaipa, Ettore Biagi

J Autoimmun· December 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Balance of Anti-CD123 Chimeric Antigen Receptor Binding Affinity and Density for the Targeting of Acute Myeloid Leukemia.
Silvia Arcangeli, Maria Caterina Rotiroti, Marco Bardelli, Luca Simonelli, Chiara Francesca Magnani, Ettore Biagi

Mol Ther· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute Myeloid Leukemia Targeting by Chimeric Antigen Receptor T Cells: Bridging the Gap from Preclinical Modeling to Human Studies.
Maria Caterina Rotiroti, Silvia Arcangeli, Monica Casucci, Vincenzo Perriello, Attilio Bondanza, Ettore Biagi

Hum Gene Ther· March 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Full GMP-compliant validation of bone marrow-derived human CD133(+) cells as advanced therapy medicinal product for refractory ischemic cardiomyopathy.
Daniela Belotti, Giuseppe Gaipa, Beatrice Bassetti, Benedetta Cabiati, Gabriella Spaltro, Ettore Biagi

Biomed Res Int· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunotherapy of acute leukemia by chimeric antigen receptor-modified lymphocytes using an improved Sleeping Beauty transposon platform.
Chiara F Magnani, Nice Turazzi, Fabrizio Benedicenti, Andrea Calabria, Erika Tenderini, Ettore Biagi

Oncotarget· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Development of advanced therapies in Italy: Management models and sustainability in six Italian cell factories.
Giuseppe Gaipa, Martino Introna, Josee Golay, Maria Luisa Nolli, Giuliana Vallanti, Ettore Biagi

Cytotherapy· April 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Donor-derived CD19-targeted T cells in allogeneic transplants.
Chiara Francesca Magnani, Andrea Biondi, Ettore Biagi

Curr Opin Hematol· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Failure of interferon-γ pre-treated mesenchymal stem cell treatment in a patient with Crohn's disease.
Andrea Taddio, Alberto Tommasini, Erica Valencic, Ettore Biagi, Giuliana Decorti

World J Gastroenterol· April 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Acute myeloid leukemia and novel biological treatments: monoclonal antibodies and cell-based gene-modified immune effectors.
Sarah Tettamanti, Chiara Francesca Magnani, Andrea Biondi, Ettore Biagi

Immunol Lett· July 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CD123 AML targeting by chimeric antigen receptors: A novel magic bullet for AML therapeutics?
Sarah Tettamanti, Andrea Biondi, Ettore Biagi, Dominique Bonnet

Oncoimmunology· May 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Immunosuppression does not affect human bone marrow mesenchymal stromal cell efficacy after transplantation in traumatized mice brain.
Francesca Pischiutta, Giovanna D'Amico, Erica Dander, Andrea Biondi, Ettore Biagi

Neuropharmacology· April 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Treatment of graft versus host disease with mesenchymal stromal cells: a phase I study on 40 adult and pediatric patients.
Martino Introna, Giovanna Lucchini, Erica Dander, Stefania Galimberti, Attilio Rovelli, Ettore Biagi

Biol Blood Marrow Transplant· March 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Inhibition of mesenchymal stromal cells by pre-activated lymphocytes and their culture media.
Erica Valencic, Claudia Loganes, Stefania Cesana, Elisa Piscianz, Giuseppe Gaipa, Ettore Biagi

Stem Cell Res Ther· January 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Allogeneic mesenchymal stem cell infusion for the stabilization of focal segmental glomerulosclerosis.
Mirco Belingheri, Lorenza Lazzari, Valentina Parazzi, Elena Groppali, Ettore Biagi

Biologicals· November 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mesenchymal stem/stromal cells: a new ''cells as drugs'' paradigm. Efficacy and critical aspects in cell therapy.
Laura de Girolamo, Enrico Lucarelli, Giulio Alessandri, Maria Antonietta Avanzini, Maria Ester Bernardo, Ettore Biagi

Curr Pharm Des· September 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Targeting of acute myeloid leukaemia by cytokine-induced killer cells redirected with a novel CD123-specific chimeric antigen receptor.
Sarah Tettamanti, Virna Marin, Irene Pizzitola, Chiara F Magnani, Greta M P Giordano Attianese, Ettore Biagi

Br J Haematol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Advanced targeted, cell and gene-therapy approaches for pediatric hematological malignancies: results and future perspectives.
Chiara F Magnani, Sarah Tettamanti, Francesca Maltese, Nice Turazzi, Andrea Biondi, Ettore Biagi

Front Oncol· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upregulation of adhesion molecules on leukemia targets improves the efficacy of cytotoxic T cells transduced with chimeric anti-CD19 receptor.
David Laurin, Virna Marin, Ettore Biagi, Irene Pizzitola, Valentina Agostoni

J Immunother· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis